Cortoss Bone Augmentation Material, Catalog Nos. 2101-0005 and 2101-0010

Shipments were transported outside of the required refrigerated temperature conditions. Potential hazards if used include nerve damage resulting in paralysis and increased potential for embolism.

On April 1, 2020, the firm distributed Urgent Medical Device Recall letters to all affected customers. Customers were informed that the product had been transported outside of the required refrigerated temperature conditions, which protect the active material components from degradation, and help maintain optimal product set time as well as optimal mechanical properties. Customers were instructed to do the following: NOTE: due to the potential hazards/risks associated with future use of product associated with these shipments, please urgently quarantine the in-scope product. 1. Immediately review the Product Recall Notification. Please forward this information to all appropriate personnel within your organization. 2. Immediately check your internal inventory to locate the product listed on the attached business reply form and list the quantity of units on the form. Each form is hospital specific and will include shipment(s) details, including customer P.O. and delivery date. 3. Use the Business Reply Form to reconcile any affected product. Complete the Business Reply Form even if there is no affected product identified. 4. Return the enclosed business reply form by email to [email protected] or fax to 201.575.4675 to confirm receipt of this notification. 5. Upon receipt of the completed Business Reply Form, Stryker will contact you to arrange for the return and replacement of your product(s). 6. After completion of the actions as described above, there are no additional actions that users can and should take to ensure that the product operates safely. - If you desire additional training associated with these instructions, please contact our Regulatory Compliance team at 201.749.8090 or by email at [email protected]. 7. Maintain awareness of this communication internally until all required actions have been completed within your facility. 8. Inform Stryker if any of the subject devices have been distributed to othe